
KCL100 ml
Opsonin Pharma Ltd.
Established / FDA-Approved Uses Treatment of hypokalemia (low blood potassium) — Potassium Chloride is indicated for patients found to have hypokalemia with or without metabolic alkalosis and more.
Potassium Chloride is not indicated for patients who are not potassium-deficient, and routine potassium supplementation is not recommended for all diuretic users without documented or anticipated hypokalemia.
| Indication | Adult Dose | Pediatric Dose |
|---|---|---|
| Prevention of hypokalemia | 16–24 mEq/day orally in divided doses | 1 mEq/kg/day or per physician's calculation based on body surface area/weight |
| Treatment of hypokalemia | 40–100 mEq/day orally in divided doses, adjusted to serum potassium and clinical response | 2–4 mEq/kg/day orally in divided doses, under close monitoring; not to exceed adult dose |
| Severe hypokalemia / unable to tolerate oral (IV) | Intravenous infusion, diluted, typically 10 mEq/hour (up to 20 mEq/hour with continuous cardiac monitoring in an intensive care setting) | Intravenous infusion strictly individualized under specialist supervision, based on weight and serum potassium, with continuous cardiac monitoring |
Dose and duration must be individualized to the patient's serum potassium level, underlying cause of deficit, renal function, and clinical response, under the direction of a physician.
Patients experiencing any signs of hyperkalemia while taking Potassium Chloride should seek immediate medical attention.
Potassium Chloride is contraindicated in patients with the following conditions:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.